These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6802530

  • 1. Failure of positive feedback of oestradiol during chronic intranasal luteinizing hormone-releasing hormone agonist treatment.
    Bergquist C, Nillius SJ, Wide L.
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):147-51. PubMed ID: 6802530
    [Abstract] [Full Text] [Related]

  • 2. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ, Bergquist C, Wide L.
    Int J Fertil; 1980 Feb; 25(3):239-46. PubMed ID: 6108935
    [Abstract] [Full Text] [Related]

  • 3. Effect of oestrogen on gonadotrophin release in stumptailed monkeys (Macaca arctoides) treated chronically with an agonist analogue of luteinizing hormone releasing hormone.
    Fraser HM.
    J Endocrinol; 1981 Dec; 91(3):525-30. PubMed ID: 6799604
    [Abstract] [Full Text] [Related]

  • 4. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
    Kuhl H, Jung C, Taubert HD.
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
    [Abstract] [Full Text] [Related]

  • 5. Rapid inhibitory effects of an LHRH agonist implant on the oestrogen-induced LH surge and the induction of a defective luteal phase after an agonist-induced ovulation in the macaque.
    Fraser HM, Lunn SF.
    Hum Reprod; 1989 Jul; 4(5):506-12. PubMed ID: 2507574
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [Abstract] [Full Text] [Related]

  • 7. Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase.
    Lemay A, Metha AE, Tolis G, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1983 May; 39(5):668-73. PubMed ID: 6404661
    [Abstract] [Full Text] [Related]

  • 8. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
    Sheehan KL, Casper RF, Yen SS.
    Am J Obstet Gynecol; 1979 Nov 15; 135(6):759-63. PubMed ID: 386801
    [Abstract] [Full Text] [Related]

  • 9. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
    Bergquist C, Nillius SJ, Wide L, Lindgren A.
    Fertil Steril; 1981 Sep 15; 36(3):339-42. PubMed ID: 6793403
    [Abstract] [Full Text] [Related]

  • 10. Chronic effects of the stimulatory luteinizing hormone-releasing hormone analogue D-Ser (TBU) 6-EA 10-LRH on the gonadotrophin and gonadal steroid secretion in women with amenorrhoea.
    Skarin G, Nillius SJ, Wide L.
    Ups J Med Sci; 1980 Sep 15; 85(2):103-12. PubMed ID: 6787767
    [Abstract] [Full Text] [Related]

  • 11. Intranasal LHRH agonist treatment for inhibition of ovulation in women: clinical aspects.
    Bergquist C, Nillius SJ, Wide L.
    Clin Endocrinol (Oxf); 1982 Jul 01; 17(1):91-8. PubMed ID: 6811167
    [Abstract] [Full Text] [Related]

  • 12. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A, Faure N.
    J Clin Endocrinol Metab; 1986 Dec 01; 63(6):1379-85. PubMed ID: 2946711
    [Abstract] [Full Text] [Related]

  • 13. Blockade of LH and FSH secretion by LH-releasing hormone, by the LH-releasing hormone analogue, buserelin, and by combined treatment with LH-releasing hormone and oestradiol benzoate.
    Schuiling GA, Pols-Valkhof N, van der Schaaf-Verdonk GC, Koiter TR.
    J Endocrinol; 1984 Dec 01; 103(3):301-9. PubMed ID: 6438265
    [Abstract] [Full Text] [Related]

  • 14. Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent.
    Bergquist C, Nillius SJ, Wide L.
    Lancet; 1979 Aug 04; 2(8136):215-7. PubMed ID: 89330
    [Abstract] [Full Text] [Related]

  • 15. Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women.
    Bergquist C, Nillius SJ, Wide L.
    Fertil Steril; 1982 Aug 04; 38(2):190-3. PubMed ID: 6809500
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control?
    Nillius SJ, Bergquist C, Wide L.
    Contraception; 1978 Jun 04; 17(6):537-45. PubMed ID: 352612
    [Abstract] [Full Text] [Related]

  • 17. Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.
    Skarin G, Nillius SJ, Wide L.
    Contraception; 1982 Jan 04; 25(1):31-9. PubMed ID: 6800690
    [Abstract] [Full Text] [Related]

  • 18. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
    Wiegelmann W, Solbach HG, Kley HK, Nieschlag E, Rudorff KH, Krüskemper HL.
    Horm Res; 1976 Jan 04; 7(1):1-10. PubMed ID: 793974
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women.
    Lemay A, Faure N, Labrie F.
    Fertil Steril; 1982 Feb 04; 37(2):193-200. PubMed ID: 6800846
    [Abstract] [Full Text] [Related]

  • 20. LHRH analogues can be luteotrophic.
    Fleming R, Coutts JR.
    Clin Endocrinol (Oxf); 1982 Dec 04; 17(6):593-9. PubMed ID: 6819902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.